1. Home
  2. SDRL vs STOK Comparison

SDRL vs STOK Comparison

Compare SDRL & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seadrill Limited

SDRL

Seadrill Limited

HOLD

Current Price

$34.85

Market Cap

2.0B

Sector

Energy

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$29.19

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDRL
STOK
Founded
2005
2014
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SDRL
STOK
Price
$34.85
$29.19
Analyst Decision
Buy
Strong Buy
Analyst Count
4
10
Target Price
$46.25
$34.50
AVG Volume (30 Days)
768.1K
812.5K
Earning Date
02-25-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.55
0.68
Revenue
$1,307,000,000.00
$205,632,000.00
Revenue This Year
$8.52
$430.24
Revenue Next Year
N/A
N/A
P/E Ratio
$63.31
$41.92
Revenue Growth
N/A
1128.17
52 Week Low
$17.74
$5.35
52 Week High
$38.43
$38.69

Technical Indicators

Market Signals
Indicator
SDRL
STOK
Relative Strength Index (RSI) 57.07 41.86
Support Level $34.61 $25.21
Resistance Level $36.25 $31.70
Average True Range (ATR) 1.43 2.05
MACD 0.01 -0.54
Stochastic Oscillator 48.19 32.81

Price Performance

Historical Comparison
SDRL
STOK

About SDRL Seadrill Limited

Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, Canada and others. The company derives maximum revenue from the United States.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: